Cobalt chloride-induced hypoxia modulates the invasive potential and matrix metalloproteinases of primary and metastatic breast cancer cells

Anticancer Research

Volumn 29, Issue 8, 2009, Pages 3131-3138

  Fu, Ou Yang ^a   Hou, Ming Feng ^a,b   Yang, Sheau Fang ^a   Huang, Soon Cen ^c,d   Lee, Wen Ying ^c,d,e  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Breast cancer; Hypoxia; Invasion; Matrix metalloproteinases

Indexed keywords

COBALT CHLORIDE; COLLAGENASE 3; GELATINASE A; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERSTITIAL COLLAGENASE; MATRILYSIN; MATRIX METALLOPROTEINASE; STROMELYSIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ARTICLE; BREAST CANCER; BREAST METASTASIS; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL STRAIN HCC1395; CELL STRAIN HCC1937; CELL STRAIN MCF 7; CELL STRAIN MDA MB 231; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZYMOGRAPHY;

ADENOCARCINOMA; ANOXIA; ANTIMUTAGENIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; COBALT; COLLAGEN; DRUG COMBINATIONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LAMININ; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR MARKERS, BIOLOGICAL;

EID: 68549122650     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Ali SM, Harvey HA and Lipton A: Metastatic breast cancer: overview of treatment. Clin Orthop Relat Res 415: S132-7, 2003.
2. Sreenath T, Matrisian LM, Stetler-Stevenson W, Gattoni-Celli S and Pozzatti RO: Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential. Cancer Res 52: 4942-4947, 1992.
3. Fingleton B: Matrix metalloproteinases: roles in cancer and metastasis. Front Biosci 11: 479-491, 2006. (Pubitemid 43258157)
4. Duffy MJ, Maguire TM, Hill A, McDermott E and O'Higgins N: Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2: 252-257. 2000. (Pubitemid 32223594)
5. Brown PD: Matrix metalloproteinase inhibitors. Breast Cancer Res Treat 52: 125-136, 1998.
6. Schultz RM, Silberman S, Persky B, Bajkowski AS and Carmichael DF: Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res 48: 5539-5545, 1988. (Pubitemid 18242603)
7. Buck TB, Yoshiji H, Harris SR, Bunce OR and Thorgeirsson UP: The effects of sustained elevated levels of circulating tissue inhibitor of metalloproteinases-1 on the development of breast cancer in mice. Ann N Y Acad Sci 878: 732-735, 1999. (Pubitemid 29353660)
8. Coussens LM, Fingleton B and Matrisian LM: Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295: 2387-2392, 2002. (Pubitemid 34270240)
9. Sparano JA, Bernardo P, Stephenson P, Gradishar WJ, Ingle JN, Zucker S and Davidson NE: Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196. J Clin Oncol 22: 4683-4690, 2004. (Pubitemid 41185077)
10. van den Oord JJ, Paemen L, Opdenakker G and de Wolf-Peeters C: Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin. Am J Pathol 151: 665-670, 1997. (Pubitemid 27385597)
11. Martin MD and Matrisian LM: The other side of MMPs: protective roles in tumor progression. Cancer Metastasis Rev 26: 717-724, 2007.
12. Hockel M and Vaupel P: Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93: 266-276, 2001. (Pubitemid 32219813)
13. Young SD, Marshall RS and Hill RP: Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci USA 85: 9533-9537, 1988.
14. Munoz-Najar UM, Neurath KM, Vumbaca F and Claffey KP: Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation. Oncogene 25: 2379-2392, 2006.
15. Zhou J, Schmid T, Schnitzer S and Brune B: Tumor hypoxia and cancer progression. Cancer Lett 237: 10-21, 2006.
16. Chaudary N and Hill RP: Hypoxia and metastasis in breast cancer. Breast Dis 26: 55-64, 2006.
17. Rankin EB and Giaccia AJ: The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 15: 678-685, 2008.
18. Miyoshi A, Kitajima Y, Ide T, Ohtaka K, Nagasawa H, Uto Y, Hori H and Miyazaki K: Hypoxia accelerates cancer invasion of hepatoma cells by up-regulating MMP expression in an HIF-1alpha-independent manner. Int J Oncol 29: 1533-1539, 2006.
19. Osinsky SP, Ganusevich, II, Bubnovskaya LN, Valkovskaya NV, Kovelskaya AV, Sergienko TK and Zimina SV: Hypoxia level and matrix metalloproteinases-2 and -9 activity in Lewis lung carcinoma: correlation with metastasis. Exp Oncol 27: 202-205, 2005.
20. Ridgway PF, Ziprin P, Alkhamesi N, Paraskeva PA, Peck DH and Darzi AW: Hypoxia augments gelatinase activity in a variety of adenocarcinomas in vitro. J Surg Res 124: 180-186, 2005. (Pubitemid 40463716)
21. Canning MT, Postovit LM, Clarke SH and Graham CH: Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells. Exp Cell Res 267: 88-94, 2001.
22. Karovic O, Tonazzini I, Rebola N, Edstrom E, Lovdahl C, Fredholm BB and Dare E: Toxic effects of cobalt in primary cultures of mouse astrocytes. Similarities with hypoxia and role of HIF-1alpha. Biochem Pharmacol 73: 694-708, 2007.
23. 2 influencing the expression and the activity of matrix metalloproteinase-2 in rat hepatic stellate cells. Zhonghua Gan Zang Bing Za Zhi 15: 654-657, 2007.
24. Gazdar AF, Kurvari V, Virmani A, Gollahon L, Sakaguchi M, Westerfield M, Kodagoda D, Stasny V, Cunningham HT, Wistuba H, Tomlinson G, Tonk V, Ashfaq R, Leitch AM, Minna JD and Shay JW: Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int J Cancer 78: 766-774, 1998. (Pubitemid 28530401)
25. Subarsky P and Hill RP: Graded hypoxia modulates the invasive potential of HT1080 fibrosarcoma and MDA MB231 carcinoma cells. Clin Exp Metastasis 25: 253-264, 2008.
26. Turcotte ML, Parliament M, Franko A and Allalunis-Turner J: Variation in mitochondrial function in hypoxia-sensitive and hypoxia-tolerant human glioma cells. Br J Cancer 86: 619-624, 2002. (Pubitemid 34185101)
27. Bartsch JE, Staren ED and Appert HE: Matrix metalloproteinase expression in breast cancer. J Surg Res 110: 383-392, 2003. (Pubitemid 36683036)
28. Balduyck M, Zerimech F, Gouyer V, Lemaire R, Hemon B, Grard G, Thiebaut C, Lemaire V, Dacquembronne E, Duhem T, Lebrun A, Dejonghe MJ and Huet G: Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro. Clin Exp Metastasis 18: 171-178, 2000.
29. Bachmeier BE, Nerlich AG, Lichtinghagen R and Sommerhoff CP: Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity. Anticancer Res 21: 3821-3828, 2001. (Pubitemid 34229247)
30. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL and Massague J: Genes that mediate breast cancer metastasis to lung. Nature 436: 518-524, 2005. (Pubitemid 41112921)
31. Acuff HB, Carter KJ, Fingleton B, Gorden DL and Matrisian LM: Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment. Cancer Res 66: 259-266, 2006. (Pubitemid 43166032)
32. Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel E, Matrisian LM and Mareel M: Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 114: 111-118, 2001. (Pubitemid 32120080)
33. Chung GG, Zerkowski MP, Ocal IT, Dolled-Filhart M, Kang JY, Psyrri A, Camp RL and Rimm DL: β-Catenin and p53 analyses of a breast carcinoma tissue microarray. Cancer 100: 2084-2092, 2004. (Pubitemid 38580325)
34. Masaki T, Matsuoka H, Sugiyama M, Abe N, Goto A, Sakamoto A and Atomi Y: Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas. Br J Cancer 84: 1317-1321, 2001. (Pubitemid 32522098)
35. Lee WY, Huang SC, Tzeng CC, Chang TL and Hsu KF: Alterations of metastasis-related genes identified using an oligonucleotide microarray of genistein-treated HCC1395 breast cancer cells. Nutr Cancer 58: 239-246, 2007.
36. Wang F, Reierstad S and Fishman DA: Matrilysin overexpression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation. Cancer Lett 236: 292-301, 2006.
37. Bodey B, Bodey B Jr, Siegel SE and Kaiser HE: Significant differences in the matrix metalloproteinase expression profiles of spontaneous medulloblastomas/primitive neuroectodermal tumors as compared with their xenografted, established tumor cell line derived counterparts. In Vivo 14: 675-682, 2000. (Pubitemid 34097530)
38. Wyatt CA, Geoghegan JC and Brinckerhoff CE: Short hairpin RNA-mediated inhibition of matrix metalloproteinase-1 in MDA-231 cells: effects on matrix destruction and tumor growth. Cancer Res 65: 11101-11108, 2005.
39. Gill JH, Kirwan IG, Seargent JM, Martin SW, Tijani S, Anikin VA, Mearns AJ, Bibby MC, Anthoney A and Loadman PM: MMP-10 is overexpressed, proteolytically active, and a potential target for therapeutic intervention in human lung carcinomas. Neoplasia 6: 777-785, 2004. (Pubitemid 40041496)
40. Ala-aho R, Ahonen M, George SJ, Heikkila J, Grenman R, Kallajoki M and Kähäri VM: Targeted inhibition of human collagenase-3 (MMP-13) expression inhibits squamous cell carcinoma growth in vivo. Oncogene 23: 5111-5123, 2004. (Pubitemid 38980344)
41. Koong AC, Denko NC, Hudson KM, Schindler C, Swiersz L, Koch C, Evans S, Ibrahim H, Le QT, Terris DJ and Giaccia A J: Candidate genes for the hypoxic tumor phenotype. Cancer Res 60: 883-887, 2000. (Pubitemid 30129520)